Skip to main content
Premium Trial:

Request an Annual Quote

ARUP, SciGene to Develop Automated DNA Test Platform

NEW YORK (GenomeWeb News) – Clinical lab firm ARUP Laboratories and SciGene said today that they will collaborate on the development of an automated platform for processing DNA samples used in microarray-based tests for genetic defects.
 
Sunnyvale, Calif.-based SciGene will contribute its ArrayPrep Target Preparation System, which is a robotic liquid handling and incubation platform, as part of the alliance. ARUP will provide scientific expertise for testing and optimizing procedures performed on the ArrayPrep.
 
The firms aim to develop a fully automated platform that would process patient samples in less than a day.
 
Financial and other terms of the partnership were not disclosed.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.